Related Party Transactions and Outside Related Director Information

Albany Molecular Research, Inc. (AMRI)

4/28/2006 Proxy Information

Mr. Kuhla was employed by Albany Molecular Research, Inc. in 2004 and focused on business development activities. He served as Executive Vice President and Organichem’s President from January 2003 through December 2003 and as President and Chief Operating Officer from July 1998 to February 2003.

Dr. D’Ambra is entitled to payments under the Company’s Technology Development Incentive Plan for amounts paid to the Company under the license agreement with Sanofi-Aventis, including 10% of all royalties paid to the Company. During 2005, Dr. D’Ambra earned the right to receive payments in the aggregate amount of $4,716,015 under this plan. Please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005, filed on March 15, 2006, for information on the Company’s licensing agreement with Sanofi-Aventis.

Mr. O’Connor is the Chief Executive Officer of Tech Valley Communications, a telecommunications company. During 2005, Tech Valley Communications was one of the providers of telephone and internet services to the Company. Tech Valley Communications was paid $171,000, $181,000 and $165,000 for services rendered to the Company in 2005, 2004, and 2003, respectively.